The Two-Year Therapy with Omalizumab in Children with Severe Persistent Uncontrolled Asthma- Dynamics of Quality of Life
Abstract
Authors
L Namazova-Baranova E Vishneva E Dobrynina A Alekseeva J Levina K Efendieva E Antonova V Smirnov I Vinyarskaya L Selimzianova D Chemakina V Kalugina